for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Genomma Lab Internacional SAB de CV

LABB.MX

前日終値

18.40MXN

変化

-0.12(-0.65%)

出来高

1,743,169

本日のレンジ

18.27

 - 

18.79

52週レンジ

11.10

 - 

19.35

∙ 約15分前の相場を表示しています。

価格

前日終値
18.52
始値
18.52
出来高
1,743,169
3か月平均出来高
38.74
高値
18.79
安値
18.27
52週高値
19.35
52週安値
11.10
発行済株式数
1,013.43
時価総額
19,408.96
予想PER
16.52
配当利回り
--

次のエベント

Q3 2019 Genomma Lab Internacional SAB de CV Earnings Release

適時開示

その他

Genomma Lab Internacional appoints new executive vice president and CFO

HR Ratings affirms rating for Genomma Lab Internacional SAB de CV

Genomma Lab Internacional SAB de CV sells Grupo Marzam for 2.93 bln pesos

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Genomma Lab Internacional SAB de CVとは

Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

業種

Biotechnology & Drugs

連絡先

Edificio Samara

Antonio Dovali Jaime no. 70 Piso 2

Colonia Santa Fe

+52.55.50810000

http://www.genommalab.com/mx/

エグゼクティブリーダーシップ

Rodrigo Alonso Herrera Aspra

Chairman of the Board, Independent Director

Maximo Juda

Chief Executive Officer

Antonio Zamora Galland

Executive Vice President, Chief Financial and Chief Administrative Officer

Marco Sparvieri

Executive Vice-President of Global Sales

Alejandro Baston Patino

Vice-President of International and Sales Development

統計

2.92 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, MXN)

2016

11.6K

2017

12.1K

2018

12.3K

2019(E)

12.8K
EPS (MXN)

2016

1.347

2017

1.340

2018

1.190

2019(E)

1.118
株価売上高倍率(過去12カ月)
20.87
株価売上高倍率(過去12カ月)
1.61
株価純資産倍率(四半期)
2.37
株価キャッシュフロー倍率
18.76
総負債/総資本(四半期)
77.26
長期負債/資本(四半期)
49.76
投資利益率(過去12カ月)
7.08
自己資本利益率(過去12カ月)
5.13

最新ニュース

最新ニュース

金融情報はリフィニティブから。すべての情報は少なくとも15分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up